Medical technology company Stryker (NYSE:SYK) reported Q2 CY2025 results topping the market’s revenue expectations, with ...

Stryker Corp (SYK) reports robust sales and EPS growth, raises full-year guidance despite ongoing supply chain issues.

Revenue (GAAP) increased 11.1% to $6.0 billion, above analyst expectations. Adjusted earnings per share rose 11.4% to $3.13, exceeding consensus estimates. Full-year 2025 guidance was raised for both ...

Insights from analysts' 12-month price targets are revealed, presenting an average target of $429.5, a high estimate of $455.00, and a low estimate of $400.00. Marking an increase of 3.18%, the ...

PORTAGE, Mich. (AP) — PORTAGE, Mich. (AP) — Stryker Corp. (SYK) on Thursday reported second-quarter net income of $884 million. The Portage, Michigan-based company said it had profit of $2.29 per ...

Stryker raised its annual profit forecast and beat quarterly profit estimates on Thursday, banking on strong demand for its medical and surgical devices.

Buying $100 In SYK: If an investor had bought $100 of SYK stock 20 years ago, it would be worth $763.69 today based on a price of $401.99 for SYK at the time of writing.

This was the stock's fifth consecutive day of losses.

Medical technology company Stryker (NYSE:SYK) will be reporting results this Thursday after market close. Here’s what you ...

Stryker (SYK) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Stryker's second-quarter 2025 results are expected to reflect strong segmental performance. However, rising costs and tariffs ...

Stryker will increase its full-year guidance after a Street-beating second quarter that saw strong demand for products and continued business momentum.